Guangzhou Michelangel Biomedical Research Institute Co., Ltd.

Guangzhou Michelangel Biomedical Research Institute Co., Ltd. was established in September 2019. The company is based on Guangdong Nanshan Pharmaceutical Innovation Research Institute and the Yangtze River Delta Pharmaceutical Advanced Research Institute of the Shanghai Institute of Pharmacy, Chinese Academy of Sciences. It has formed joint alliances with multiple domestic and foreign pharmaceutical technology research and development institutions, universities, and pharmaceutical production enterprises, including India's Kangkade Biopharmaceutical, Canada's IPC, Guangdong Institute of Health Research, and Jiangsu Angel Pharmaceutical. The company is committed to the development of pharmaceutical formulations (including pharmaceutical and clinical research), and is committed to the full life cycle development of drugs Project management, consulting, and MAH outsourcing can continuously and efficiently provide services to pharmaceutical enterprises.